Jens Pfannkuche

Chief Executive Officer at GILUPI GmbH

Commercial Services

Health Technology

Profile

Jens Pfannkuche is currently the Managing Director at GILUPI GmbH since 2016.
Prior to this, he worked as the Head of Business Development at B·R·A·H·M·S GmbH from 2007 to 2012.

Jens Pfannkuche active positions

Companies	Position	Start
GILUPI GmbH GILUPI GmbH Medical SpecialtiesHealth Technology GILUPI GmbH develops and produces products for the in-vivo isolation of rare cells from the circulation. Its product GILUPI CellCollector enables the detection of rare cells directly from the blood of patients. The company was founded by Klaus Lücke, Ulrich Pison, Michael Giersig, and Fabian Rüchardt in 2006 and is headquartered in Potsdam, Germany.	Chief Executive Officer	2016-06-30

All active positions of Jens Pfannkuche

Former positions of Jens Pfannkuche

Companies	Position	End
B·R·A·H·M·S GmbH B·R·A·H·M·S GmbH Miscellaneous Commercial ServicesCommercial Services B·R·A·H·M·S GmbH engages in the development and manufacture of novel diagnostic testing procedures. Its products include B·R·A·H·M·S PCT (Procalcitonin), MR-proADM (Mid-regional proadrenomedullin), Copeptin proAVP, Neopterin, and KRYPTOR Instruments. The company was founded in 1994 and is headquartered in Hennigsdorf, Germany.	Corporate Officer/Principal	2012-04-30

See the detail of Jens Pfannkuche's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jens Pfannkuche's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
B·R·A·H·M·S GmbH B·R·A·H·M·S GmbH Miscellaneous Commercial ServicesCommercial Services B·R·A·H·M·S GmbH engages in the development and manufacture of novel diagnostic testing procedures. Its products include B·R·A·H·M·S PCT (Procalcitonin), MR-proADM (Mid-regional proadrenomedullin), Copeptin proAVP, Neopterin, and KRYPTOR Instruments. The company was founded in 1994 and is headquartered in Hennigsdorf, Germany.	Commercial Services
GILUPI GmbH GILUPI GmbH Medical SpecialtiesHealth Technology GILUPI GmbH develops and produces products for the in-vivo isolation of rare cells from the circulation. Its product GILUPI CellCollector enables the detection of rare cells directly from the blood of patients. The company was founded by Klaus Lücke, Ulrich Pison, Michael Giersig, and Fabian Rüchardt in 2006 and is headquartered in Potsdam, Germany.	Health Technology